Cargando…

The Renoprotective Effects of Naringenin (NGN) in Gestational Pregnancy

INTRODUCTION: Gestational diabetes mellitus (GDM) is defined as glucose intolerance that is first diagnosed during pregnancy, a condition risking the health of both the mother and the baby. Naringenin (NGN) has been demonstrated to have multiple therapeutic functions, while it is also considered to...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Chunrong, Yin, Xiufeng, Zhao, Chunping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6955625/
https://www.ncbi.nlm.nih.gov/pubmed/32021351
http://dx.doi.org/10.2147/DMSO.S231851
_version_ 1783486971992080384
author Zhao, Chunrong
Yin, Xiufeng
Zhao, Chunping
author_facet Zhao, Chunrong
Yin, Xiufeng
Zhao, Chunping
author_sort Zhao, Chunrong
collection PubMed
description INTRODUCTION: Gestational diabetes mellitus (GDM) is defined as glucose intolerance that is first diagnosed during pregnancy, a condition risking the health of both the mother and the baby. Naringenin (NGN) has been demonstrated to have multiple therapeutic functions, while it is also considered to exhibit antidiabetic properties. The present study aimed to investigate the protective effects of NGN in pregnant diabetic rats. METHODS: GDM was induced by feeding the rats with a high-fat diet for 5 weeks, followed by intraperitoneal injection of streptozotocin (35 mg/kg). The fasting blood glucose were determined with a glucometer and the 24-h urine protein (24-UPro) were determined by the sulfonyl salicylic acid method. The pathological morphological changes and apoptosis of glomeruli cells of kidney tissue using hematoxylin and eosin (H&E) staining and TUNEL analysis. Enzyme-linked immunosorbent assay (ELISA) kits were used to detect the serum T-AOC, the activity of SOD, the levels of GSH-Px, CAT and MDA, TNF-α, IL-6, TGF-β, ICAM-1.The expression of related genes were measured by RT-qPCR and Western blot analyses. RESULTS: In the NGN-treated group, it was observed that the general status of the rats was improved, while the levels of blood glucose and 24-UPro were significantly decreased. In addition, the histopathological changes in renal tissues and renal cell apoptosis were significantly improved upon treatment with NGN. The expression levels of oxidative stress and inflammation-associated factors also differed signifigcantly between the model and NGN-treated groups. Upon treatment with NGN, the levels of peroxisome proliferator-activated receptor α were significantly increased, while the activity of enzymes involved in the oxidative metabolism of fatty acids was significantly decreased. CONCLUSION: These preliminary experimental findings demonstrate that NGN has a certain renoprotective effect on GDM, which provides a novel therapeutic option for this condition.
format Online
Article
Text
id pubmed-6955625
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-69556252020-02-04 The Renoprotective Effects of Naringenin (NGN) in Gestational Pregnancy Zhao, Chunrong Yin, Xiufeng Zhao, Chunping Diabetes Metab Syndr Obes Original Research INTRODUCTION: Gestational diabetes mellitus (GDM) is defined as glucose intolerance that is first diagnosed during pregnancy, a condition risking the health of both the mother and the baby. Naringenin (NGN) has been demonstrated to have multiple therapeutic functions, while it is also considered to exhibit antidiabetic properties. The present study aimed to investigate the protective effects of NGN in pregnant diabetic rats. METHODS: GDM was induced by feeding the rats with a high-fat diet for 5 weeks, followed by intraperitoneal injection of streptozotocin (35 mg/kg). The fasting blood glucose were determined with a glucometer and the 24-h urine protein (24-UPro) were determined by the sulfonyl salicylic acid method. The pathological morphological changes and apoptosis of glomeruli cells of kidney tissue using hematoxylin and eosin (H&E) staining and TUNEL analysis. Enzyme-linked immunosorbent assay (ELISA) kits were used to detect the serum T-AOC, the activity of SOD, the levels of GSH-Px, CAT and MDA, TNF-α, IL-6, TGF-β, ICAM-1.The expression of related genes were measured by RT-qPCR and Western blot analyses. RESULTS: In the NGN-treated group, it was observed that the general status of the rats was improved, while the levels of blood glucose and 24-UPro were significantly decreased. In addition, the histopathological changes in renal tissues and renal cell apoptosis were significantly improved upon treatment with NGN. The expression levels of oxidative stress and inflammation-associated factors also differed signifigcantly between the model and NGN-treated groups. Upon treatment with NGN, the levels of peroxisome proliferator-activated receptor α were significantly increased, while the activity of enzymes involved in the oxidative metabolism of fatty acids was significantly decreased. CONCLUSION: These preliminary experimental findings demonstrate that NGN has a certain renoprotective effect on GDM, which provides a novel therapeutic option for this condition. Dove 2020-01-08 /pmc/articles/PMC6955625/ /pubmed/32021351 http://dx.doi.org/10.2147/DMSO.S231851 Text en © 2020 Zhao et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Zhao, Chunrong
Yin, Xiufeng
Zhao, Chunping
The Renoprotective Effects of Naringenin (NGN) in Gestational Pregnancy
title The Renoprotective Effects of Naringenin (NGN) in Gestational Pregnancy
title_full The Renoprotective Effects of Naringenin (NGN) in Gestational Pregnancy
title_fullStr The Renoprotective Effects of Naringenin (NGN) in Gestational Pregnancy
title_full_unstemmed The Renoprotective Effects of Naringenin (NGN) in Gestational Pregnancy
title_short The Renoprotective Effects of Naringenin (NGN) in Gestational Pregnancy
title_sort renoprotective effects of naringenin (ngn) in gestational pregnancy
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6955625/
https://www.ncbi.nlm.nih.gov/pubmed/32021351
http://dx.doi.org/10.2147/DMSO.S231851
work_keys_str_mv AT zhaochunrong therenoprotectiveeffectsofnaringeninngningestationalpregnancy
AT yinxiufeng therenoprotectiveeffectsofnaringeninngningestationalpregnancy
AT zhaochunping therenoprotectiveeffectsofnaringeninngningestationalpregnancy
AT zhaochunrong renoprotectiveeffectsofnaringeninngningestationalpregnancy
AT yinxiufeng renoprotectiveeffectsofnaringeninngningestationalpregnancy
AT zhaochunping renoprotectiveeffectsofnaringeninngningestationalpregnancy